- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
PI Industries Ltd. reported stable performance for Q3 FY25, with consolidated revenue at Rs. 19,008 million, marginally up by 0.2% year-on-year. The domestic revenue saw a 5% growth driven primarily by biological products, which increased by approximately 20%. In the last nine months, revenue grew by 4%, reflecting a CAGR of 17%. EBITDA for the quarter was Rs. 5,122 million, showing a decline of 8%, and the net profit dropped 17% to Rs. 3,727 million, attributed to increased overhead costs and a higher effective tax rate (ETR). The board has approved an interim dividend of Rs. 6.00 per share for FY24-25. The company's focus on launching new products continues, with significant contributions from agri-chemical exports, which grew around 40% year-on-year.
Investor implications remain positive as the company is strategically progressing with new product launches and improving cash flow, with free cash generation supporting growth investments and strong balance sheet metrics, including a net worth increase to Rs. 98,660 million. Continued attention to margin management and disciplined working capital could offer robust potential moving forward.